VRDN Factor-Based Stock Analysis | Nasdaq
Below is Validea’s guru fundamental report for VIRIDIAN THERAPEUTICS INC (VRDN). Of the 22 guru strategies we follow, VRDN rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
VIRIDIAN THERAPEUTICS INC (VRDN) is a small-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 52% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically…
